High-Throughput Sequencing of TCR Gene Rearrangements as a Useful Tool for Identifying and Tracking Minimal/Measurable Residual Disease (MRD) in Lymphoid Malignancies

November 02, 2022

PRESENTED BY
Jack Tung, MD, PhD – Stanford University